BTRC and non-small cell lung carcinoma: Consistent with a recent report [216], the silencing of β-TrCP1/2 induces apoptosis by upregulating BCL2-interacting mediator of cell death extra-long (BimEL) in both gefitinib-sensitive and gefitinib-resistant NSCLC cells [217].